/PRNewswire/ The "Global Chemotherapy-Induced Peripheral Neuropathy Market, By Therapy, By Region, Estimation & Forecast, 2017 - 2030" report has been added.
BioDelivery Sciences International (NASDAQ:BDSI – Get Rating) announced its quarterly earnings data on Wednesday. The specialty pharmaceutical company reported $0.62 EPS for the quarter, beating the consensus estimate of $0.02 by $0.60, Fidelity Earnings reports. BioDelivery Sciences International had a net margin of 18.81% and a return on equity of 27.47%. Shares of BioDelivery Sciences […]
Stockholder-plaintiff Michael Zomber filed a complaint against BioDelivery Sciences International Inc., and the Chairman of the Board of the Company and